Case-Based Roundtable Meetings Spotlight
Case-Based Roundtable Meeting Spotlight October 2 2021
Case-Based Roundtable Meeting Spotlight September 2021:Hematologic Malignancies
Case-Based Roundtable Meeting Spotlight September 2021: Solid Tumors
Case-Based Roundtable Meetings Spotlight August 2021: Solid Tumors
Case-Based Roundtable Meetings Spotlight August 2021: Hematologic Malignancies
Case-Based Roundtable Meetings Spotlight July 1 2021
Case-Based Roundtable Meetings Spotlight July 2 2021
Case-Based Roundtable Meetings Spotlight June 2021: Hematologic Malignancies
Case-Based Roundtable Meetings Spotlight June 2021: Solid Tumors
Case-Based Roundtable Meetings Spotlight May 2021: Solid Tumors
Case-Based Roundtable Meetings Spotlight May 2021: Hematologic Malignancies
Case-Based Roundtable Meetings Spotlight April 2, 2021
Case-Based Roundtable Meetings Spotlight April 1, 2021
Case-Based Roundtable Meetings Spotlight March 2021: Solid Tumors
Case-Based Roundtable Meetings Spotlight March 2021: Hematologic Malignancies
Case-Based Roundtable Meeting Spotlight February 2 2021
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Enfortumab Vedotin Plus Pembrolizumab Improves Survival in MIBC
2
Teclistamab/Daratumumab Earns FDA Priority Voucher for R/R Myeloma
3
Early Relapse Guides Use of CAR T vs Other Options in LBCL
4
FDA Grants Regular Approval to Rucaparib for BRCA-Mutated mCRPC
5